US$ 20.50
aod9604 clinical trials weight loss efficacy AOD 9604 From BPC-157 to TB-500 to
Description
2018 Jul 12
Let's say your vial contains 50mg of AHK-Cu powder

Formulated in a stabilized pre-mixed injection pen for SubQ administration , 5-Amino-1MQ ensures high systemic bioavailability and precise delivery for controlled experimental research

How It Works AOD9604 is a modified fragment of the Cterminal region of human growth hormone (amino acids 177191) that appears to mimic GHs effects on fat metabolism without significantly affecting IGF1 or overall growth hormone levels

Research in corneal healing has led to clinical development of Thymosin Beta-4 formulations

The difference between AHK Cu and GHK Cu: 1
